ReNeuron pioneers new treatments for neurological disordersKLegal has advised Merlin Biosciences on the first biotech public-to-private transaction to close in the UK.

The deal saw Merlin – through its bid vehicle St James’ MGP – launch a successful public recommended takeover of the AIM-listed research company ReNeuron Holdings.